SCHEMBL23879296

SCHEMBL23879296

[CH2]C1CCN(c2ccnc3nccnc23)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSB P07858 2/20 0.36
AKT2 P31751 1/20 0.36
MAPT P10636 4/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MITF O75030 1/20 0.35
HTT P42858 1/20 0.35
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
SLC6A4 P31645 1/20 0.33
GRM4 Q14833 2/20 0.32
TNNI3 P19429 1/20 0.32
TNNT2 P45379 1/20 0.32
TNNC1 P63316 1/20 0.32
ALDH1A1 P00352 2/20 0.31
MAPK1 P28482 2/20 0.31
NCF1 P14598 2/20 0.31
KDM4E B2RXH2 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PIK3CD O00329 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18980017 0.80 PDE10A (0.42)
SCHEMBL18980406 0.80 ROCK2 (0.47) CTSBAKT2PIK3CAROCK2ROCK1
SCHEMBL19000049 0.79 MAPT (0.48) MAPTSMN1; SMN2MITFHTTTNNI3
SCHEMBL30571032 0.79 MAPT (0.48) MAPTSMN1; SMN2MITFHTTTNNI3
SCHEMBL30571028 0.79 MAPT (0.48) MAPTSMN1; SMN2MITFHTTTNNI3
Hydrochloric Acid SCHEMBL18980008 0.78 ROCK2 (0.46) CTSBAKT2PIK3CAROCK2ROCK1
SCHEMBL18980404 0.77 KDM4E (0.46) AKT2MAPTALDH1A1KDM4EL3MBTL1
SCHEMBL19026586 0.76 ROCK2 (0.43) CTSBAKT2MAPTSMN1; SMN2MITF
SCHEMBL18980565 0.74 LDHA (0.35) CTSBMAPT
SCHEMBL20658609 0.73 NOTUM (0.54) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3889146-A1 POLYHETEROCYCLIC TLR7/8 ANTAGONISTS AND THEIR USES FOR TREATING IMMUNE DISORDERS Merck Patent GmbH (DE) 2021-10-06 EP disclosed
EP-3889145-A1 8-CYANO-5-PIPERIDINO-QUINOLINES AS TLR7/8 ANTAGONISTS AND THEIR USES FOR TREATING IMMUNE DISORDERS Merck Patent GmbH (DE) 2021-10-06 EP disclosed